Amyotrophic Lateral Sclerosis
FY23 Clinical Biomarker Development Award
The list of Fiscal Year 2023 Amyotrophic Lateral Sclerosis Research Program Clinical Biomarker Development Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
Beth Israel Deaconess Medical Center | Seward Rutkove |
Johns Hopkins University | Steven Zeiler |
Massachusetts Institute of Technology | Ernest Fraenkel |
The Leland Stanford Junior University | Ying Lu |
University of California, Los Angeles | Roel Ophoff |
Last updated Friday, December 1, 2023